tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Adam Maeder, 186 are a BUY (75%), 55 are a HOLD (22.18%), 7 are a SELL (2.82%).
Analyst Adam Maeder, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 62.42% that have a potential upside of 32.54% achieved within 144 days.
Adam Maeder’s has documented 499 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NVRO, Nevro Corp at 12-Nov-2024.
Analyst best performing recommendations are on ZYXI (ZYNEX).
The best stock recommendation documented was for SILK (SILK ROAD MEDICAL) at 1/13/2021. The price target of $58 was fulfilled within 1 day with a profit of $2.98 (5.42%) receiving and performance score of 54.16.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$10
$13
1 years 11 months 7 days ago
(23-Jan-2023)
1/2 (50%)
$0.16 (1.63%)
70
Hold
$10
$10
1 years 11 months 26 days ago
(04-Jan-2023)
3/4 (75%)
$0.12 (1.21%)
193
Hold
$10
$14
2 years 1 months ago
(30-Nov-2022)
1/5 (20%)
$-0.13 (-1.28%)
13
Buy
$9
$-1 (-10.00%)
$13
2 years 7 months 26 days ago
(04-May-2022)
1/3 (33.33%)
$3.44 (61.87%)
209
Buy
$12
$2 (20.00%)
$14
2 years 10 months 7 days ago
(23-Feb-2022)
9/13 (69.23%)
$6.64 (123.88%)
124
Which stock is Adam Maeder is most bullish on?
Which stock is Adam Maeder is most reserved on?
What Year was the first public recommendation made by Adam Maeder?
